Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Testosterone Pretreatment in Poor Responders
NCT06195163Phase 4Not yet recruiting
- Sponsor
- Instituto Bernabeu
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Testosterone TEPI patch in Diminished Ovarian Reserve (DOR) and female infertility (2 arms), sponsored by Instituto Bernabeu. Primary endpoint: Number of cumulus-oocyte complexes. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on NCT06195163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06195163.